Baltimore biotech firm, PathSensors, announced that its CEO, Ted Olsen, joined with other leaders of the Maryland Biohealth community in developing and issuing recommendations to grow Maryland's biohealth industry and position the state as a globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023.

The recommendations are contained in a report from the Maryland Life Sciences Advisory Board (LSAB). The report made recommendations around four key areas: assets, connectivity, capital and talent, or ACCT Now.

• Leverage and grow the state’s assets and accelerate the commercialization of research;
• Increase connectivity among and awareness of the state’s biohealth assets and resources;
• Increase availability and access to capital for Maryland biohealth businesses, from early-stage startups to advanced-stage companies;
• Grow the state’s talent pool of experienced biohealth entrepreneurs, business leaders, graduates and scientists with commercially relevant experience.

“I’m honored to have the opportunity to serve on the LSAB,” Mr. Olsen commented. “PathSensor’s has benefited greatly from the wonderful resources and people in Maryland’s biotech community.”

Mr. Olsen was appointed to the LSAB in 2016 by Governor Hogan, and serves alongside distinguished members including Maryland Commerce Secretary Mike Gill, John Wasilisin, president and COO of the Maryland Technology Development Corp. (TEDCO), University of Maryland, Baltimore President Dr. Jay A. Perman, and Dr. Christopher P. Austin, director of the National Center for Advancing Translational Studies at NIH.

For more information about the LSAB and to read the full report, click here.

About PathSensors, Inc.
PathSensors is a leading biotechnology solutions and environmental testing company. aPathSensors provides high speed, highly sensitive pathogen and threat detection solutions for the defense, homeland security, public health, medical countermeasures, mail room screening, first responder, food processing and agricultural sectors. PathSensors’ innovative BioFlash and Zephyr detection systems use CANARY® technology licensed from the MIT-Lincoln Laboratory and are deployed by government and commercial agencies due to their speed, accuracy and ease-of-use. For more information, visit http://www.pathsensors.com. For more information, please visit http://www.PathSensors.com